Tech Company Financing Transactions
Esperance Pharmaceuticals Funding Round
Esperance Pharmaceuticals secured a $5 million Series A investment round on 2/6/2009. Investors included BVM Capital.
Transaction Overview
Company Name
Announced On
2/6/2009
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Series A
Investors
BVM Capital (Ross Barrett)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
909 Fannin St. 2000
Houston, TX 77010
USA
Houston, TX 77010
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Esperance Pharmaceuticalsdevelops anticancer drugsthat kill cancer cells without harming normal cells.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Hector Alila
Chief Financial Officer
Clarice Motter
VP - R & D
Carola Leuschner
Browse more venture capital transactions:
Prev: 2/6/2009: SynergEyes venture capital transaction
Next: 2/6/2009: IronKey venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs